Donald Pinto
Bristol-Myers Squibb (United States)(US)
Publications by Year
Research Areas
Blood Coagulation and Thrombosis Mechanisms, Atrial Fibrillation Management and Outcomes, Coagulation, Bradykinin, Polyphosphates, and Angioedema, Venous Thromboembolism Diagnosis and Management, Vitamin K Research Studies
Most-Cited Works
- → Apixaban Metabolism and Pharmacokinetics after Oral Administration to Humans(2008)601 cited
- → Mechanism of selective inhibition of the inducible isoform of prostaglandin G/H synthase.(1994)410 cited
- → Discovery of 1-(4-Methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro- 1H-pyrazolo[3,4-c]pyridine-3-carboxamide (Apixaban, BMS-562247), a Highly Potent, Selective, Efficacious, and Orally Bioavailable Inhibitor of Blood Coagulation Factor Xa(2007)391 cited
- → 125I-labelled fibrinogen in the diagnosis of deep-vein thrombosis and its correlation with phlebography(1968)310 cited
- → Apixaban, an oral, direct and highly selective factor Xa inhibitor: in vitro, antithrombotic and antihemostatic studies(2008)299 cited
- → Preclinical discovery of apixaban, a direct and orally bioavailable factor Xa inhibitor(2011)194 cited